Pharmalittle: Trump may not approve FDA emergency use guidelines
The U.K. will host the world’s first Covid-19 challenge trials, in which healthy volunteers are deliberately infected with coronavirus.
The U.K. will host the world’s first Covid-19 challenge trials, in which healthy volunteers are deliberately infected with coronavirus.
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to…
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.
A controversial provision of a federal law designed to speed copycat drugs to market and foster competition saved Medicare Part D nearly $15 billion from
“By filing bogus patent listings, pharma companies block competition and inflate the cost of prescription drugs,” said FTC Chair Lina Khan.
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
In a challenge to the pharmaceutical industry, Doctors Without Borders has revealed the detailed costs of a study it ran for a tuberculosis treatment regimen.
In a challenge to the pharmaceutical industry, Doctors Without Borders has revealed the detailed costs of a study it ran for a tuberculosis treatment regimen.
The pharmaceutical industry saw its image slip last year among patient advocacy groups, according to a new survey.
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
The authors of a new study argue the heralded arrival of biosimilars failed to fully deliver on their promise.